Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation

American Journal of Cardiology

Volumn 114, Issue 1, 2014, Pages 42-46

  Osugi, Naohiro ^a   Suzuki, Susumu ^a   Ishii, Hideki ^a   Yasuda, Yoshinari ^a   Shibata, Yohei ^a   Tatami, Yosuke ^a   Ota, Tomoyuki ^a   Kawamura, Yoshihiro ^a   Okumura, Satoshi ^a   Tanaka, Akihito ^a   Inoue, Yosuke ^a   Matsuo, Seiichi ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CORONARY STENT; DRUG ELUTING STENT; ELECTIVE CORONARY STENT IMPLANTATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART MUSCLE INJURY; HUMAN; IMPLANTATION; INCIDENCE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PERIPROCEDURAL MYOCARDIAL INJURY; PRIORITY JOURNAL;

AGED; ALBUMINURIA; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEART INJURIES; HUMANS; INCIDENCE; MALE; MYOCARDIAL ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS; STENTS; TROPONIN T;

EID: 84902256077     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.058     Document Type: Article

References (29)

1. H.C. Gerstein, J.F. Mann, Q. Yi, B. Zinman, S.F. Dinneen, B. Hoogwerf, J.P. Hallé, J. Young, A. Rashkow, C. Joyce, S. Nawaz, S. Yusuf HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426
2. H.L. Hillege, V. Fidler, G.F. Diercks, W.H. van Gilst, D. de Zeeuw, D.J. van Veldhuisen, R.O. Gans, W.M. Janssen, D.E. Grobbee, P.E. de Jong Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777 1782
3. J.P. Garg, and G.L. Bakris Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease Vasc Med 7 2002 35 43
4. P. Clausen, J.S. Jensen, G. Jensen, K. Borch-Johnsen, and B. Feldt-Rasmussen Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects Circulation 103 2001 1869 1874
5. D.W. Park, Y.H. Kim, S.C. Yun, J.M. Ahn, J.Y. Lee, W.J. Kim, S.J. Kang, S.W. Lee, C.W. Lee, S.W. Park, and S.J. Park Frequency, causes, predictors,and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention Eur Heart J 34 2013 1662 1669
6. F.M. Costa, J. Ferreira, C. Aguiar, H. Dores, J. Figueira, and M. Mendes Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years Eur Heart J 33 2012 2544 2550
7. S. Kumagai, H. Ishii, T. Amano, T. Uetani, B. Kato, K. Harada, T. Yoshida, H. Ando, A. Kunimura, Y. Shimbo, K. Kitagawa, K. Harada, M. Hayashi, D. Yoshikawa, T. Matsubara, and T. Murohara Impact of chronic kidney disease on the incidence of peri-procedural myocardial injury in patients undergoing elective stent implantation Nephrol Dial Transpl 27 2012 1059 1063
8. American Diabetes Association Standards of medical care in diabetes - 2012 Diabetes Care 35 2012 11 63
9. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, H.A. Katus, F.S. Apple, B. Lindahl, D.A. Morrow, B.A. Chaitman, P.M. Clemmensen, P. Johanson, H. Hod, R. Underwood, J.J. Bax, R.O. Bonow, F. Pinto, R.J. Gibbons, K.A. Fox, D. Atar, L.K. Newby, M. Galvani, C.W. Hamm, B.F. Uretsky, P.G. Steg, W. Wijns, J.P. Bassand, P. Menasché, J. Ravkilde, E.M. Ohman, E.M. Antman, L.C. Wallentin, P.W. Armstrong, M.L. Simoons, J.L. Januzzi, M.S. Nieminen, M. Gheorghiade, G. Filippatos, R.V. Luepker, S.P. Fortmann, W.D. Rosamond, D. Levy, D. Wood, S.C. Smith, D. Hu, J.L. Lopez-Sendon, R.M. Robertson, D. Weaver, M. Tendera, A.A. Bove, A.N. Parkhomenko, E.J. Vasilieva, S. Mendis ESC Committee for Practice Guidelines (CPG) Third universal definition of myocardial infarction review Eur Heart J 33 2012 2551 2567
10. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, K. Nitta, K. Yamagata, Y. Tomino, H. Yokoyama, A. Hishida Collaborators developing the Japanese equation for estimated GFR Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
11. T. Ninomiya, V. Perkovic, B.E. de Galan, S. Zoungas, A. Pillai, M. Jardine, A. Patel, A. Cass, B. Neal, N. Poulter, C.E. Mogensen, M. Cooper, M. Marre, B. Williams, P. Hamet, G. Mancia, M. Woodward, S. Macmahon, J. Chalmers ADVANCE Collaborative Group Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes J Am Soc Nephrol 20 2009 1813 1821
12. E. Gerdts, V. Papademetriou, V. Palmieri, K. Boman, H. Björnstad, K. Wachtell, T.D. Giles, B. Dahlöf, R.B. Devereux Losartan Intervention For End (LIFE) point reduction in hypertension study Life study (urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction Am J Cardiol 89 2002 399 402
13. C.A. Jones, M.E. Francis, M.S. Eberhardt, B. Chavers, J. Coresh, M. Engelgau, J.W. Kusek, D. Byrd-Holt, K.M. Narayan, W.H. Herman, C.P. Jones, M. Salive, and L.Y. Agodoa Microalbuminuria in the US population: third National Health and Nutrition Examination Survey Am J Kidney Dis 39 2002 445 459
14. M. Lee, J.L. Saver, K.H. Chang, H.W. Liao, S.C. Chang, and B. Ovbiagele Impact of microalbuminuria on incident stroke: a meta-analysis Stroke 41 2010 2625 2631
15. F. Schiele, N. Meneveau, R. Chopard, V. Descotes-Genon, J. Oettinger, M.F. Seronde, F. Briand, Y. Bernard, F. Ecarnot, J.P. Bassand Réseau de Cardiologie de Franche Comte Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction Am Heart J 157 2009 327 333
16. W. Turaj, A. Słowik, U. Wyrwicz-Petkow, J. Pankiewicz, T. Iskra, M. Rudzińska, and A. Szczudlik The prognostic significance of microalbuminuria in non-diabetic acute stroke patients Med Sci Monit 7 2001 989 994
17. P. Rein, A. Vonbank, C.H. Saely, S. Beer, V. Jankovic, C. Boehnel, J. Breuss, L. Risch, P. Fraunberger, and H. Drexel Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease Am J Cardiol 107 2011 1144 1148
18. R. Sukhija, W.S. Aronow, P. Kakar, L. Garza, R. Sachdeva, A. Sinha, and J.L. Mehta Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus Am J Cardiol 98 2006 279 281
19. Y.J. Hong, M.H. Jeong, Y.H. Choi, J.A. Song, K. Ahmed, D.H. Kim, K.H. Lee, M.G. Lee, K.H. Park, D.S. Sim, N.S. Yoon, H.J. Yoon, K.H. Kim, H.W. Park, J.H. Kim, Y. Ahn, J.G. Cho, J.C. Park, and J.C. Kang Relationship between microalbuminuria and vulnerable plaque components in patients with acute coronary syndrome and with diabetes mellitus. Virtual histology-intravascular ultrasound Circ J 75 2011 2893 2901
20. Chronic Kidney Disease Prognosis Consortium K. Matsushita, M. van der Velde, B.C. Astor, M. Woodward, A.S. Levey, P.E. de Jong, J. Coresh, and R.T. Gansevoort Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
21. D.E. Rifkin, R. Katz, M. Chonchol, L.F. Fried, J. Cao, I.H. de Boer, D.S. Siscovick, M.G. Shlipak, and M.J. Sarnak Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly Nephrol Dial Transpl 25 2010 1560 1567
22. C.D. Stehouwer, and Y.M. Smulders Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms J Am Soc Nephrol 17 2006 2106 2111
23. J.A. Jefferson, S.J. Shankland, and R.H. Pichler Proteinuria in diabetic kidney disease: a mechanistic viewpoint Kidney Int 74 2008 22 36
24. J. Redon, and F. Martinez Microalbuminuria as surrogate endpoint in therapeutic trials Curr Hypertens Rep 14 2012 345 349
25. L. Palaniappan, M. Carnethon, and S.P. Fortmann Association between microalbuminuria and the metabolic syndrome: NHANES III Am J Hypertens 2003 952 958
26. S. Araki, M. Haneda, T. Sugimoto, M. Isono, K. Isshiki, A. Kashiwagi, and D. Koya Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes Diabetes 54 2005 2983 2987
27. S. Araki, M. Haneda, D. Koya, H. Hidaka, T. Sugimoto, M. Isono, K. Isshiki, M. Chin-Kanasaki, T. Uzu, and A. Kashiwagi Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes Diabetes 56 2007 1727 1730
28. H. Ibsen, M.H. Olsen, K. Wachtell, K. Borch-Johnsen, L.H. Lindholm, C.E. Mogensen, B. Dahlöf, R.B. Devereux, U. de Faire, F. Fyhrquist, S. Julius, S.E. Kjeldsen, O. Lederballe-Pedersen, M.S. Nieminen, P. Omvik, S. Oparil, and Y. Wan Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study Hypertension 45 2005 198 202
29. A.S. Hutchison, D.S. O'Reilly, and A.C. MacCuish Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria Clin Chem 34 1988 2019 2021